Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The use of nicotine replacement therapy in pregnancy has been debated but evidence suggests that it is safer than smoking. A cross-sectional survey was conducted with: (i) general practitioners and obstetricians from a college database; and (ii) general practitioners with a special interest in Indigenous health. General practitioners had higher odds of prescribing compared to obstetricians. Reading guidelines, confidence, viewing nicotine replacement therapy as safe, effective and with good adherence, also significantly increased the odds of prescription. Clear guidance regarding safety and efficacy, with practical clinical protocols, are required in order to reduce variation in prescribing rates across these clinicians.

Cite

CITATION STYLE

APA

Bar-Zeev, Y., Bonevski, B., Gruppetta, M., Twyman, L., Atkins, L., Palazzi, K., … Gould, G. S. (2018). Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners. Australian and New Zealand Journal of Obstetrics and Gynaecology, 58(3), 366–370. https://doi.org/10.1111/ajo.12751

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free